Nemolizumab improves symptoms in prurigo nodularis: Clinical trial
For patients with moderate-to-severe prurigo nodularis, nemolizumab improves symptoms, according to a study published in the Oct. 26 issue of the New England Journal of Medicine.
Oct 27, 2023
0
0